Clinical trial

Evaluation of Pharmacogenetic Testing In a Mental Health Population and Economic Outcomes

NCT02474680

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

GENETIC · Unmapped registry intervention Pharmacogenetic testing Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Evaluation of Pharmacogenetic Testing In a Mental Health Population and Economic Outcomes

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2015-11-01

PhaseN/A

Conditions

Major Depressive Disorder 1verified · MONDO: major depressive disorder 1

Interventions

Pharmacogenetic testingGENETIC

Sponsors & collaborators

Avera McKennan Hospital & University Health Centerlead sponsor

Mapped research locations

Sioux FallsSouth Dakota, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02474680 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.